David V. Goeddel, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 247,640 shares at $4.85 ($1.2M) on 2022-10-26, disclosed to the SEC on 2022-10-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 51,046 | $242K | 20.4% |
| 2 | $4.75 | 51,046 | $242K | 20.4% |
| 3 | $4.85 | 72,774 | $353K | 29.6% |
| 4 | $4.85 | 72,774 | $353K | 29.6% |
| Total | $4.81 avg | 247,640 | $1.2M | 100% |
| Filing → |
| NGM | BUY | 2023-11-17 | $18K | — | Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |